Additional Information
Market:ASX
Sector:General Mining
EPIC:UTO
Latest Price: 0.10  (0.00%)
52-week High:0.23
52-week Low:0.07
Market Cap:10.34M
1 year chart
digital-look imported chart image
1 day chart
digital-look imported chart image
U308

U3O8 (ASX: UTO) is a dedicated uranium exploration company with projects in Western Australia, Queensland, New South Wales and South Australia. The Company controls 44 exploration licences, 33 of which are granted and 11 of which are under application, for a total area of almost 6500 square kilometres.

 

Most of the Company's projects are 100% owned by U3O8 Limited, but the Company does have a major joint venture with Cameco in the Ashburton, is farming into eleven tenements held by Northern Star Resources in the East Kimberley, and more recently has signed a joint venture and farm in agreement with World Uranium on the Mango Bore project in the Gascoyne.  All joint ventures are in Western Australia.

U308 releases results from sampling program on Ashburton Joint Venture

Tuesday, November 24, 2009
U308 releases results from sampling program on Ashburton Joint Venture

Shares in uranium exploration company U308 (ASX: UTO) have jumped almost 20% after it announced further results from the recent soil and rock chip sampling programme completed on the U3O8 – Cameco Australia Ashburton Joint Venture in Western Australia.

News of the results saw the share price in U308 rise 19.8%, or 2.5c, to 15.5c.

The Ashburton Project comprises 14 granted tenements prospective for unconformity style uranium mineralisation and is situated south of Paraburdoo in Western Australia.

All but one of the tenements form part of the U3O8 Limited – Cameco Australia Ashburton 50:50 Joint Venture which is operated by U3O8.

Samples were collected from a number of prospects on the Canyon Creek tenement and assayed for a range of elements including rare earth elements, precious and base metals, arsenic, and uranium.

Significant rare earth assays received from Livento prospect included results of 2.56%, 3.71%, 10.83% and 11.05% REO (rare earth oxide). The same samples returned significant uranium results of up to 0.094% U, and were also anomalous in base metals and other elements.

A solitary sample was collected from the Sirius prospect some distance to the north- northwest. This sample returned significant rare earth elements to 9.01% REO, uranium to 0.16% U, whilst being anomalous in other elements including lead at 0.73% Pb.

Further rock chip and soil samples are still to be received from the Ashburton project area.

Detailed ground electromagnetic survey to follow up airborne electromagnetic anomalies was recently completed, while follow up rock chip sampling is currently underway.

 

 

No investment advice

The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.